首页|卵巢癌患者肿瘤细胞减灭术后复发风险的列线图模型构建

卵巢癌患者肿瘤细胞减灭术后复发风险的列线图模型构建

扫码查看
目的 构建卵巢癌患者肿瘤细胞减灭术(CRS)术后复发风险的列线图预测模型.方法 回顾性选取2019年6月至2022年6月在郑州大学附属郑州中心医院接受CRS治疗后1 a内复发的52例卵巢癌患者为发生组,另选取同期于医院接受CRS治疗后1 a内未复发的52例卵巢癌患者为未发生组.对比两组临床病历资料,通过logistic回归分析构建卵巢癌患者CRS术后复发风险的列线图预测模型,通过受试者工作特征(ROC)曲线评估预测效能.结果 发生组有糖尿病史占比、术前糖类抗原(CA125)水平、人附睾蛋白4(HE4)水平高于未发生组,ALB水平低于未发生组(P<0.05).经logistic回归分析显示,糖尿病CA125、HE4、白蛋白(ALB)是卵巢癌患者CRS术后复发的影响因素(P<0.05).绘制列线图构建卵巢癌患者CRS术后复发的风险预测模型,验证模型区分度显示C-index值=0.904,具有良好的区分度;Hosmer-Lemeshow拟合优度检验结果显示该模型拟合良好(P=0.327);绘制标准曲线显示,校准曲线和Y-X直线相近,模型准确度良好;对模型预测效能进行验证,结果显示预测模型评估卵巢癌患者CRS术后复发的曲线下面积(AUC)为0.904,预测效能好.决策曲线显示,列线图风险预测模型对卵巢癌患者CRS术后复发预测具有重要临床价值.结论 糖尿病、术前CA125、HE4、术前ALB是卵巢癌患者CRS术后复发的影响因素,基于上述指标所得的列线图风险预测模型预测价值较好.
Construction of a Nomogram Model for the Risk of Recurrence After Tumor Cytoreductive Surgery in Ovarian Cancer Patients
Objective To construct a nomogram model for the risk of postoperative recurrence in ovarian cancer patients undergoing tumor cytoreductive surgery(CRS).Methods Retrospectively select 52 ovarian cancer patients who experienced recurrence within 1 year after receiving CRS treatment at Zhengzhou Central Hospital Affiliated to Zhengzhou University from June 2019 to June 2022 as the occurrence group,and another 52 ovarian cancer patients who did not relapse within 1 year after receiving CRS treatment at the hospital during the same period as the non-occurrence group.The clinical medical records were compared between the two groups,and a column chart prediction model for postoperative recurrence risk of CRS in ovarian cancer patients was constructed through logistic regression analysis.The predictive performance was evaluated through receiver operating characteristic(ROC)curve.Results The proportion of diabetes history,preoperative carbohydrate antigen(CA125)level,and human epididymal protein 4(HE4)level in the occurrence group were higher than those in the non-occurrence group,while the ALB level was lower than that in the non-occurrence group(P<0.05).Logistic regression analysis showed that diabetes CA125,HE4,albumin(ALB)were the influencing factors for the recurrence of ovarian cancer patients after CRS(P<0.05).Draw a column chart to construct a risk prediction model for postoperative recurrence of CRS in ovarian cancer patients,and verify that the model's discrimination shows a C-index value of 0.904,which has good discrimination.The results of the Hosmer-Lemeshow goodness of fit test show that the model fits well(P=0.327).Draw a standard curve to show that the calibration curve is similar to the Y-X line,and the model accuracy was good.The predictive performance of the model was validated,and the results showed that the area under the curve(AUC)of the predictive model for evaluating postoperative recurrence of CRS in ovarian cancer patients was 0.904,indicating good predictive performance.The decision curve shows that the column chart risk prediction model has important clinical value in predicting postoperative recurrence of CRS in ovarian cancer patients.Conclusion Diabetes,preoperative CA125,HE4 and preoperative ALB are the influencing factors of postoperative recurrence of ovarian cancer patients with CRS.The nomogram risk prediction model based on the above indicators has good predictive value.

ovarian cancertumor cytoreductive surgeryrecurrencenomogram model

王淑丽、李红娟、陈玲灵、刘会敏、田晓娜

展开 >

郑州大学附属郑州中心医院妇产科,河南郑州 450000

卵巢癌 肿瘤细胞减灭术 复发 列线图模型

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(2)
  • 16